<p>Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF</p>-Reference-Cited by-同舟云学术

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF

Published:2020-07 Issue: Volume:Volume 13 Page:7447-7458
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Tian Bo,Xiao Yuhang,Ma Junliang,Ou Wei,Wang Hui,Wu Jie,Tang Jinming,Zhang Baihua,Liao Xiaojuan,Yang Desong,Wu Zhining,Li Xu,Zhou Yong,Su Min,Wang Wenxiang

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference61 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Epidemiology of Esophageal Squamous Cell Carcinoma

3. Oesophageal carcinoma

4. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update

5. Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action;International Journal of Molecular Sciences;2024-09-04

2. Role of microRNAs in tumor progression by regulation of kinesin motor proteins;International Journal of Biological Macromolecules;2024-06

3. A Comparison between Bulgarian Tanacetum parthenium Essential Oil from Two Different Locations;Molecules;2024-04-25

4. Chemotherapeutics;Pharmacognosy;2024

5. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway;Cancer Chemotherapy and Pharmacology;2023-12-23